Establishes and requires coverage for routine opt-out HIV testing during provision of medical care in certain settings.

2026-2027 Regular Session Introduced by John Burzichelli

Requires routine opt-out HIV testing in designated medical care settings to normalize screening, with counseling, privacy, and linkage to care guaranteed.

Summary of Bill S 4579 (Session 222) – New Jersey

Purpose and intent

Establishes an obligation for healthcare providers to offer routine opt-out HIV testing during the provision of medical care in specified settings.

Aims to normalize HIV screening as part of standard medical care, improve early detection, and reduce barriers to testing by integrating it into routine services.

Key provisions and changes

Routine opt-out testing: Healthcare settings must offer HIV testing to patients as part of standard medical care, with testing conducted unless the patient explicitly declines (opt-out).

Settings covered: The bill applies to designated medical care environments where patients receive routine services. (Exact settings specified in the bill text; typically includes primary care, emergency departments, clinics, and other care sites.)

Consent framework: Shifts from an explicit opt-in model to an opt-out approach, meaning patients are presumed to be tested unless they decline.

Counseling and informed consent: Requires appropriate pre-test information and post-test counseling consistent with public health guidelines, while ensuring patient autonomy and understanding of the test, results, and next steps.

Confidentiality and reporting: Maintains patient privacy for HIV test results and outlines handling, storage, and reporting in accordance with state confidentiality laws and public health reporting requirements.

Follow-up and linkage to care: Mandates clear pathways for confirmatory testing, notification of results, and linkage to HIV care and preventive services for those who test positive or at risk.

Non-discrimination and anti-stigma measures: Provisions to safeguard patients against discrimination or stigma based on HIV testing status.

Who would be affected

Patients receiving medical care in covered settings: Individuals would be offered HIV testing as part of routine care and would have the option to opt out.

Healthcare providers and facilities: Clinics, hospitals, and other medical care providers would implement the routine opt-out testing protocol, documentation, and counseling requirements.

Public health systems: Enhanced testing could influence HIV surveillance, linkage-to-care programs, and resource allocation for prevention and treatment services.

Procedural and timeline aspects

Implementation timeline: The bill outlines a phased or specified timeline for rolling out the routine opt-out testing framework (exact dates/details would be in the bill’s text).

Compliance and oversight: Establishes requirements for training, credentialing, and monitoring to ensure adherence to the routine testing mandate.

Exceptions and safeguards: Likely includes medical or ethical exceptions (e.g., patients who cannot consent, emergent situations) and processes for managing declines.

Practical considerations

Public health impact: Potentially increases HIV screening rates, leads to earlier diagnosis, and improves linkage to care and prevention services.

Patient experience: Balances routine testing with respect for patient autonomy and informed decision-making through the opt-out model.

Data and privacy: Emphasizes confidentiality and proper handling of sensitive HIV status information.

If you’d like, I can tailor this summary to focus on specific sections of the bill (e.g., consent process, settings covered, or reporting requirements) or compare it to existing New Jersey HIV testing laws.